研究成果: |
张欢博士已作为项目负责人承担科研项目3项,其中国家级2项,获得经费60余万元;共发表SCI论文29篇,代表性论文发表在Acta Pharmaceutica Sinica B,Journal of Controlled Release,Biomaterials,Advanced Science等杂志上。申请发明专利5项,其中授权2项。 代表性论文: 1. Huan Zhang#, Man Sun#, Jiayi Chen, Simiao Wang, Jiayi Liu, Hongqun Yang, Luotong Liu, Siyuan Hu, Fang Yang, Lesheng Teng, Zhou Chen, Xiaobing Wang, Shiyan Dong, Yifan Ma, Jared L. Edwards, Xiaotian Wang, Yen-Tzu Chang, Betty Y.S. Kim, Wen Jiang*, Yaxin Cui*, and Zhaogang Yang*, Immunological conversion of triple-negative breast cancer by engineered extracellular vesicle-mediated pyroptosis, Journal of Controlled Release, 2026, 389: 114493 (影响因子:12.4). 2. Huan Zhang#, Jianming Xing#, Man Sun, Yaxin Cui, Yulai Li, Siyuan Hu, Xinhe Wang, Hao Jiang, Yun Zhang, Xuanjie Jiang, Fang Yang, Betty Y.S. Kim, Wen Jiang, Zhaogang Yang* and Lesheng Teng*, Engineered exosomes for targeted microRNA delivery to reverse liver fibrosis, Biomaterials, 2025, 324: 123510 (影响因子:13.6). 3. Man Sun#, Huan Zhang#, Yarui Ma#, Simiao Wang, Jiayi Chen, Yaxin Cui, Yun Zhang, Siyuan Hu, Dan Zhou, Pengchen Zhang, Yahui Liu, Betty Y.S. Kim, Wen Jiang, Xiaobing Wang*, and Zhaogang Yang*, In situ programming of the tumor microenvironment to alleviate immunosuppression for pancreatic cancer immunotherapy, Advanced Science, 2025, e04008 (影响因子:14.1). 4. Huan Zhang#, Adam Grippin#, Man Sun, Yifan Ma, Betty Y.S. Kim, Lesheng Teng, Wen Jiang*, and Zhaogang Yang*, New avenues for cancer immunotherapy: cell-mediated drug delivery systems, Journal of Controlled Release, 2024, 375, 712-732 (影响因子:12.4). 5. Huan Zhang, Jie Yang, Rongze Sun, Songren Han, Zhaogang Yang, Lesheng Teng*, Microfluidics for nano-drug delivery systems: from fundamentals to industrialization, Acta Pharmaceutica Sinica B, 2023;13(8):3277-3299 (影响因子:14.6). 代表性科研项目: 1. 国家自然科学基金青年C类项目,基于聚焦纳秒脉冲微流控的工程化外泌体构建及其重塑骨肉瘤基质屏障增强免疫治疗的机制研究,2027.01-2029.12,30万元,在研,主持 2. 首批国家自然科学基金青年学生基础研究项目(博士研究生),具备跨越ECM靶向调控aHSCs的多功能外泌体的构建及其肝纤维化治疗的研究,2024.05-2025.12,30万元,结题,主持 3. 吉林大学研究生创新研究计划,具备靶向肿瘤逆转肿瘤微环境的工程化外泌体的构建及其在非小细胞肺癌免疫治疗中的应用,2024.03-2025.03,4000元,结题,主持 4. 国家自然科学基金面上项目,具备肿瘤杀伤及逆转肿瘤微环境的载药功能化中性粒细胞的构建及其在非小细胞肺癌治疗中的应用,2021.01-2024.12,56万元,结题,参与 5. 吉林省科技厅项目,脑胶质瘤动物模型应用于多功能外泌体载药平台的构建及研究(20250206003ZP),2025.01-2028.12,48万元,在研,参与 |